Show simple item record

dc.contributor.authorRajeswaran, Thurkka
dc.contributor.authorPlymen, Carla M.
dc.contributor.authorDoherty, Anne M.
dc.date.accessioned2019-09-09T12:21:54Z
dc.date.available2019-09-09T12:21:54Z
dc.date.issued2017-11-26
dc.identifier.citationRajeswaran, Thurkka, Plymen, Carla M., & Doherty, Anne M. (2018). The effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression – a systematic review. International Journal of Psychiatry in Clinical Practice, 22(3), 164-169. doi: 10.1080/13651501.2017.1401085en_IE
dc.identifier.issn1471-1788
dc.identifier.urihttp://hdl.handle.net/10379/15410
dc.description.abstractDepression is associated with increased morbidity, mortality and hospital readmission in patients with heart failure (HF). This systematic review aimed to compile studies examining whether the use of antidepressants could improve outcome in patients with HF and concomitant depression. The electronic libraries Embase, OVID MEDLINE(R) and PsychInfo were used to search the following terms 'heart failure' AND 'anti-depressants'; 'heart failure' AND 'TCA' OR 'SSRI' OR 'SNRI'. The result of this database search was analysed to select papers that satisfied our inclusion criteria. Of the 180 papers found in the original database search, only three met the inclusion criteria. A further two papers were added from hand-searching through the references. Three of these papers are randomised controlled trials (RCT); the other two, cohort studies. All studies show that antidepressants are well tolerated in this group. There was no significant difference in depressive symptoms between the test and placebo. The cardiac outcomes of patients with HF are not improved by the use of antidepressants relative to placebo. Antidepressants are not associated with increased mortality rate as established in previous papers. However, there is inadequate evidence that the use of antidepressants effects significant improvement in depression or cardiac outcomes.en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherTaylor & Francisen_IE
dc.relation.ispartofInternational Journal Of Psychiatry In Clinical Practiceen
dc.subjectCardiac failureen_IE
dc.subjectdepressionen_IE
dc.subjectdepressive episodeen_IE
dc.subjectantidepressive agentsen_IE
dc.subjectmortalityen_IE
dc.titleThe effect of antidepressant medications in the management of heart failure on outcomes: mortality, cardiovascular function and depression - a systematic reviewen_IE
dc.typeArticleen_IE
dc.date.updated2019-08-26T12:57:31Z
dc.identifier.doi10.1080/13651501.2017.1401085
dc.local.publishedsourcehttps://doi.org/10.1080/13651501.2017.1401085en_IE
dc.description.peer-reviewedpeer-reviewed
dc.internal.rssid17398909
dc.local.contactAnne Doherty, School Of Medicine, Nui Galway. Email: anne.doherty@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionACCEPTED
nui.item.downloads27


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record